Venture Capital & Private Equity

Chapel Hill, N.C. – September 12, 2026 -- TrueBridge Capital Partners has closed its second dedicated venture secondaries fund, TrueBridge Secondaries II, L.P., with $508 million in commitments, more than double the size of its predecessor.

Fund more than doubles predecessor's $230 million haul from 2024

Secondaries II was oversubscribed and drew capital from new and existing investors, including foundations, endowments, pension funds, family offices, and high-net-worth individuals. It follows TrueBridge Secondaries I, which closed at $230 million in 2024 as the firm's first dedicated venture secondaries vehicle.

Bled, Slovenia – September 08, 2026 -- A new data-driven selection model has identified 100 high-growth Slovenian companies that doubled their combined revenue to 2.1 billion euros, marking the first full rollout of a methodology designed to close Europe's competitiveness gap with the United States and China.

Future 100 Slovenia becomes the pilot for a pan-European scale-up strategy

The Future 100 Slovenia initiative, unveiled at the Future 500 Forum in Bled, is the first national application of the Future 500 Initiative's methodology, which its backers intend to extend across Europe. The forum ran alongside the Bled Strategic Forum under the theme 'Powering Europe's Scale-Up Engine: From Selection to Acceleration.'

Bled – September 07, 2026 -- A new data-driven selection model has identified 100 high-growth Slovenian companies whose combined revenue doubled to €2.1 billion, marking the first full deployment of the Future 500 initiative designed to close the competitiveness gap between Europe, the United States and China.

Future 100 Slovenia index debuts as EU readies €80 billion in growth-company funding

The index was unveiled at the Future 500 forum in Bled, timed to test whether Europe can identify its most promising scale-ups early enough to connect them with the capital and networks needed for global competitiveness. The launch coincides with the European Investment Bank's ICTE 2.0 initiative, which is mobilizing up to €80 billion in investment for young growth companies across the bloc.

New York – September 07, 2026 -- The Women's Capital Summit will convene investors, league executives and founders to examine capital flows into women's sports and women-led businesses, positioning the sector as an increasingly sophisticated investment market rather than an emerging niche.

Sophia Bush joins summit to advocate for capital deployment into women's sports

Actor and investor Sophia Bush will speak at the Summit on the case for backing women's sports and women entrepreneurs, drawing on her track record of investing in women-focused businesses and initiatives.

SHERIDAN, WYOMING - April 14, 2026 - Hale Capital Management has closed Fund V, lifting total assets under management to $334 million and cementing its strategy of partnering with management teams to build and reinvent lower-middle-market national security and technology businesses. The close arrives alongside a cluster of portfolio transactions spanning defense software, real estate data analytics, critical infrastructure security, and AI-driven insurance risk management. Together, the developments position Hale Capital as an increasingly active participant across restructuring, growth equity, and structured debt in government-adjacent technology markets. Recent liquidity events and new platform acquisitions underscore how the firm is deploying capital ahead of and alongside Fund V.

SHERIDAN, WYOMING - April 14, 2026 - Bluestone Investment Partners, a private equity firm headquartered in McLean, Virginia, focuses exclusively on lower middle-market companies in the defense and government services sector. The firm's principals bring direct experience spanning corporate strategy, government regulation, defense spending dynamics, and sector-specific market trends - positioning Bluestone as a specialist alternative to generalist PE firms competing for deals in a fragmented industry. Portfolio companies receive both capital and functional expertise across strategy, sales, legal, finance, and mergers and acquisitions.

SHERIDAN, WYOMING - April 14, 2026 - Claret Capital Partners, a London-headquartered independent growth debt fund manager, has surpassed 200 portfolio companies and deployed more than €1.2 billion in growth capital since its 2013 founding, with deal activity accelerating sharply across the first quarter of 2026. The 200th-company milestone was reached with an investment in SIS Medical in January 2026, marking a tangible threshold for a firm that has built its franchise on non-dilutive debt instruments for expansion-stage SMEs. Operating across technology, life sciences, and climate tech, Claret targets revenue-generating businesses seeking capital without proportional equity dilution-a proposition that has gained institutional traction as venture equity markets have remained selective for growth-stage companies.

SHERIDAN, WYOMING - December 04, 2025 - Cresta Fund Management is expanding its senior leadership team to support the next phase of growth, appointing industry veteran David Altshuler as Partner and Head of Capital Formation and promoting two long-standing team members into expanded roles. The Dallas-based private equity firm, which focuses on energy infrastructure across industrial, logistics and agricultural sectors, is sharpening its institutional capital-raising capabilities as limited partners seek specialist managers with operational depth and clear energy-transition strategies.

Bringing a Capital Formation Heavyweight Into the Partnership

SHERIDAN, WYOMING – August 08, 2025 – A wave of high-value licensing deals between multinational pharmaceutical companies and Chinese biotechs is reshaping the global drug development landscape. While the headlines highlight billion-dollar transactions, the reality on the ground is a complex mix of opportunity and survival for China’s crowded biotech sector.

Licensing as a Strategic Lifeline
Out-licensing overseas rights has become a critical strategy for Chinese biotechs facing tightened capital flows and rising operational pressures. For many, partnering with multinational corporations is not simply a growth choice — it’s a means to stay in business. Executives across China’s leading hubs, from Shanghai Zhangjiang Pharma Valley to Suzhou’s BioBAY, report that companies have been cutting staff, selling assets, or closing entirely since 2022.

SHERIDAN, WYOMING – July 25, 2025 – Philips Foundation has announced the results of its 2024 activities in a newly published Annual Report, celebrating a milestone year that brought quality healthcare access to 46.5 million people globally—up from 28 million in 2023. The results mark a significant stride toward the Foundation’s 2030 goal of reaching 100 million underserved individuals each year.

Strategic Projects and Investments Drive Expansion

Throughout 2024, the Foundation initiated 22 new healthcare projects and five early-stage impact investments, with a strategic focus on primary care in underserved regions, particularly in India and Latin America. These initiatives leveraged Philips' health technology expertise to address rising non-communicable disease burdens and maternal health challenges.